Bukowski Rm

556 total citations
18 papers, 430 citations indexed

About

Bukowski Rm is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Bukowski Rm has authored 18 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Bukowski Rm's work include Renal cell carcinoma treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Metastasis and carcinoma case studies (2 papers). Bukowski Rm is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Metastasis and carcinoma case studies (2 papers). Bukowski Rm collaborates with scholars based in United States. Bukowski Rm's co-authors include Hewlett Js, Harris Jw, Weick Jk, R. Gahbauer, Pontes Je, Sewa S. Legha, Robert M. OʼBryan, G Chéchile, James E. Montie and John H. Saiki and has published in prestigious journals such as PubMed.

In The Last Decade

Bukowski Rm

18 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bukowski Rm United States 9 240 166 110 100 76 18 430
Takamasa Katagiri Japan 15 268 1.1× 351 2.1× 129 1.2× 25 0.3× 52 0.7× 65 641
Bruce K. Wiseman United States 5 235 1.0× 181 1.1× 105 1.0× 75 0.8× 442 5.8× 10 685
Dan Birmingham United States 14 381 1.6× 77 0.5× 80 0.7× 264 2.6× 39 0.5× 20 731
Maria Goldaniga Italy 16 141 0.6× 248 1.5× 157 1.4× 47 0.5× 302 4.0× 39 647
Daniel Tsai United States 5 153 0.6× 56 0.3× 206 1.9× 36 0.4× 56 0.7× 11 510
Shanhua Zou China 13 102 0.4× 217 1.3× 87 0.8× 24 0.2× 75 1.0× 29 438
David J. Gnarra United States 9 82 0.3× 246 1.5× 53 0.5× 26 0.3× 86 1.1× 14 405
Devesh Mewar United Kingdom 11 198 0.8× 116 0.7× 59 0.5× 21 0.2× 52 0.7× 18 571
Filiz Şen United States 16 124 0.5× 117 0.7× 213 1.9× 19 0.2× 163 2.1× 42 623
Chiara Vendramin Italy 9 134 0.6× 95 0.6× 62 0.6× 42 0.4× 206 2.7× 19 377

Countries citing papers authored by Bukowski Rm

Since Specialization
Citations

This map shows the geographic impact of Bukowski Rm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bukowski Rm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bukowski Rm more than expected).

Fields of papers citing papers by Bukowski Rm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bukowski Rm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bukowski Rm. The network helps show where Bukowski Rm may publish in the future.

Co-authorship network of co-authors of Bukowski Rm

This figure shows the co-authorship network connecting the top 25 collaborators of Bukowski Rm. A scholar is included among the top collaborators of Bukowski Rm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bukowski Rm. Bukowski Rm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rm, Bukowski. (2000). Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.. PubMed. 27(2). 204–12. 40 indexed citations
2.
Rm, Bukowski. (1994). Biologic therapy in patients receiving salvage treatment.. PubMed. 21(4 Suppl 7). 96–9. 3 indexed citations
3.
Falk, Gary W., et al.. (1991). Acute colonic pseudo-obstruction associated with interleukin-2 therapy.. PubMed. 86(10). 1539–41. 4 indexed citations
4.
Chéchile, G, James E. Montie, Pontes Je, & Bukowski Rm. (1990). Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.. PubMed. 353. 153–61. 6 indexed citations
5.
Barna, Barbara P., et al.. (1990). Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma.. PubMed. 9(3). 319–28. 9 indexed citations
6.
Oishi, Noboru, et al.. (1987). Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.. PubMed. 71(12). 1307–8. 5 indexed citations
7.
Considine, Bryden, et al.. (1983). Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.. PubMed. 67(5). 421–4. 5 indexed citations
8.
Fl, Meyskens, et al.. (1983). Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.. PubMed. 67(7-8). 697–700. 8 indexed citations
9.
Drelichman, Anibal, et al.. (1983). Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.. PubMed. 67(12). 1139–40. 2 indexed citations
10.
Rm, Bukowski. (1982). Thrombotic thrombocytopenic purpura: a review.. PubMed. 6. 287–337. 118 indexed citations
11.
Rm, Bukowski, et al.. (1982). Treatment of severe aplastic anemia with antithymocyte globulin.. PubMed. 10(9). 809–16. 13 indexed citations
12.
Rm, Bukowski, et al.. (1982). Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.. PubMed. 66(8). 1651–2. 12 indexed citations
13.
Gahbauer, R., et al.. (1981). Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.. PubMed. 65(3-4). 219–22. 28 indexed citations
14.
Rm, Bukowski, et al.. (1980). Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.. PubMed. 3(4). 321–4. 26 indexed citations
15.
Rm, Bukowski, Albert F. LoBuglio, Joseph D. McCracken, & R Pugh. (1980). Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.. PubMed. 64(12). 1387–8. 2 indexed citations
16.
Rm, Bukowski, et al.. (1979). Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.. PubMed. 63(5). 795–6. 30 indexed citations
17.
Rm, Bukowski, et al.. (1977). Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.. PubMed. 61(7). 1375–7. 4 indexed citations
18.
Rm, Bukowski, et al.. (1976). Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura.. PubMed. 13(3). 219–32. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takamasa Katagiri Breakdown of academic impact, for papers by Bruce K. Wiseman Breakdown of academic impact, for papers by Dan Birmingham Breakdown of academic impact, for papers by Maria Goldaniga Breakdown of academic impact, for papers by Daniel Tsai Breakdown of academic impact, for papers by Shanhua Zou Breakdown of academic impact, for papers by David J. Gnarra Breakdown of academic impact, for papers by Devesh Mewar Breakdown of academic impact, for papers by Filiz Şen Breakdown of academic impact, for papers by Chiara Vendramin
Rankless by CCL
2026